Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Sep 24, 2026
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $7.15 million as of September 25, 2026. Its market cap has increased by 14.45% in one year.
Market Cap
7.15M
Enterprise Value
10.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
ChartMarket Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.35M to 7.15M, a decrease of -68.00%. That is a compound annual growth rate of -5.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 7.15M | 23.46% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 11.59M |
| Oncotelic Therapeutics | 11.15M |
| Brainstorm Cell Therapeutics | 9.60M |
| OSR Health | 8.60M |
| Hepion Pharmaceuticals | 7.76M |
| Adaptimmune Therapeutics | 6.89M |
| TRON Group | 6.44M |
| LianMedical | 6.44M |